Institute for Biomedical Imaging I²BM – CEA


I²BM - the CEA Institute for Biomedical Imaging is a unique research center for biomedical imaging recognized internationally that brings together/groups three research infrastructures: MIRCen, NeuroSpin and Service Hospitalier Frédéric Joliot (SHFJ). Each infrastructure hosts state-of-the-art technical platforms and highly qualified neuroscience research teams able to both run/ exploit in vivo imaging at the forefront of their research - including its clinical transfer- and to generate new challenges for methodological developments in imaging. Set on 30,000 m² of imaging platforms, the I²BM gathers nearly 500 researchers, clinicians, doctors, engineers, technicians, doctoral and post-doctoral students from CEA, Inserm, CNRS, AP-HP and INRIA.

> Learn more about I²BM

MIRCen Molecular Imaging Research Center, a CEA preclinical research center based in Fontenay aux Roses, is a partnership between the CEA and INSERM. MIRCen consists of a set of platforms (8,500 m2) and one hundred researchers, engineers, technicians, clinicians and students from CEA, INSERM and CNRS dedicated to the development of animal models relevant to human pathologies and to the preclinical assessment of gene-, cell- and drug-based therapies for the treatment of neurodegenerative diseases. MIRCen is therefore the ideal place to undertake translational research projects to propose, characterize and measure in animals and then in humans, the therapeutic efficacy of new treatments.

The different imaging platforms (PET, MRI, NMR spectroscopy) are used not only to assess neurodegeneration in animal models (in the long-term in patients) but also to test innovative therapeutic strategies.

> Learn more about MIRCen

NeuroSpin is a high field MRI neuroimaging center based at CEA center in Saclay that develops tools and models to better analyze the human brain during development, functionally in vivo, and brain disorders such as neurological and psychiatric diseases.

>Learn more about NeuroSpin



The SHFJ - Service Hospitalier Frédéric Joliot is a preclinical and clinical research center specialized in molecular and functional imaging, associated to a clinical nuclear medicine department. Pioneer in Europe in the field of PET molecular imaging, especially for imaging of neurotransmission and quantification of membrane receptors, it is based in the Orsay-Longjumeau Hospital.

> Learn more about SHFJ